publication date: Jan. 17, 2014


Baylor Campus to Build Joint Cancer Center

BAYLOR COLLEGE OF MEDICINE, CHI St. Luke’s Health and the Texas Heart Institute have expanded their educational, clinical and research affiliations in conjunction with Catholic Health Initiatives, which sponsors and operates the newly named CHI St. Luke’s Health.

Baylor and CHI St. Luke’s signed a joint-venture agreement to open a new, acute-care, open-staff hospital on Baylor’s McNair Campus, which will eventually replace the current CHI St. Luke’s hospital in the Texas Medical Center. Baylor and CHI St. Luke’s will jointly operate the new hospital.

The three organizations will also develop a joint cancer center on the campus of the new hospital. Baylor is now home to an NCI-designated cancer center, and the goal would be for the center to achieve comprehensive status.

Wayne Keathley, formerly president of the Baylor College of Medicine Medical Center and Health Network, was appointed to serve as president of the medical center that will include the existing hospital and the hospital that will be completed on the McNair Campus. He will also be an executive of CHI.

Plans also call for community cancer centers across the region. The joint venture does not include Baylor’s outpatient clinics or its physicians. CHI plans to invest more than $1 billion in the region’s health care infrastructure over the next five years.

J. ROBERT BECK was named deputy director and chief academic and administrative officer of Fox Chase Cancer Center.

Beck holds the H.O. West and J.R. Wike Chair in Cancer Research, and will also retain the title of chief medical officer for the present. In his new roles, … Continue reading 40-03 In Brief

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.